Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 1.00 |
| ▸ | LCK | P06239 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | NQO2 | P16083 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | TTR | P02766 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Caffeoyl Aldehyde SCHEMBL663936 | 1.00 | XDH (1.00) | XDHLCKKDM4ERAB9APTGS2 | |
| Caffeoyl Aldehyde SCHEMBL30610040 | 1.00 | XDH (1.00) | XDHLCKKDM4ERAB9APTGS2 | |
| Caffeoyl Aldehyde SCHEMBL15861833 | 0.98 | XDH (0.96) | XDHLCKKDM4ERAB9APTGS2 | |
| SCHEMBL19473606 | 0.82 | XDH (0.69) | XDHLCKKDM4ERAB9APTGS2 | |
| SCHEMBL14143630 | 0.82 | XDH (0.69) | XDHLCKKDM4ERAB9APTGS2 | |
| SCHEMBL14087957 | 0.82 | XDH (0.69) | XDHLCKKDM4ERAB9APTGS2 | |
| SCHEMBL31706727 | 0.81 | LCK (1.00) | XDHLCKKDM4ERAB9APTGS2 | |
| SCHEMBL30631591 | 0.81 | LCK (1.00) | XDHLCKKDM4ERAB9APTGS2 | |
| SCHEMBL1824175 | 0.81 | LCK (1.00) | XDHLCKKDM4ERAB9APTGS2 | |
| SCHEMBL1824176 | 0.81 | LCK (1.00) | XDHLCKKDM4ERAB9APTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108752212-B | 9-decarboxylated rosmarinic acid analogue and synthetic method and application thereof | 北京大学 | 2024-03-12 | — | — | CN | claimed |
| CN-117659104-A | Degradable Schiff base antifouling agent containing polyphenol structure and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-03-08 | — | — | CN | claimed |
| EP-3423429-B1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | UNIV DE MONCTON (CA) | 2023-07-12 | — | — | EP | claimed |
| CN-115711902-A | qNMR determination method of coffee total diterpene and application thereof | 中国科学院昆明植物研究所 | 2023-02-24 | — | — | CN | claimed |
| CN-115322182-A | Azole antifungal compound and application thereof | 广西医科大学 | 2022-11-11 | — | — | CN | claimed |
| CN-108774274-B | Sialylmethyl ester methyl glycoside derivative and synthesis method and application thereof | 北京大学 | 2020-11-03 | — | — | CN | claimed |
| CN-108774274-A | Sialic acid methyl esters first glycoside derivates and its synthetic method and application | 北京大学 | 2018-11-09 | — | — | CN | claimed |
| CN-108752212-A | 9- decarboxylation Rosmarinic acid analogs and its synthetic method and application | 北京大学 | 2018-11-06 | — | — | CN | claimed |
| CN-105985389-A | Phenylethanoid glycoside analogue and synthesis method and application thereof | 北京大学 | 2016-10-05 | — | — | CN | claimed |
| US-20090324750-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PSEUDOLYSIMACHION LONGIFOLIUM AND THE CATALPOL DERIVATIVES ISOLATED THEREFROM HAVING ANTIINFLAMMATORY, ANTIALLERGIC AND ANTIASTHMATIC ACTIVITY | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-12-31 | — | — | US | claimed |
| US-6303567-B1 | FOR DIAGNOSIS AND THERAPY OF AMYLOIDOGENIC DISEASES SUCH AS ALZHEIMER'S DISEASE | PRAECIS PHARMACEUTICALS, INC . | 2001-10-16 | — | — | US | claimed |
| EP-0785190-B1 | Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK & CHEMICALS (JP) | 2000-08-16 | — | — | EP | claimed |
| US-5985242-A | PEPTIDE OF 3 TO 5 D-AMINO ACIDS; MAY BE MODIFIED AT AMINO-AND/OR CARBOXY TERMINUS; FOR TREATMENT OF AMYLOIDOSIS, ALZHEIMER'S DISEASE | PRAECIS PHARMACEUTICALS, INC. (US) | 1999-11-16 | — | — | US | claimed |
| EP-0929574-A1 | MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | Praecis Pharmaceuticals Incorporated (US) | 1999-07-21 | — | — | EP | claimed |
| WO-1998008868-A9 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | — | 1998-05-28 | — | — | WO | claimed |
| CN-1038327-C | Process for preparation of cephalosporin derivative | PFIZER (US) | 1998-05-13 | — | — | CN | claimed |
| WO-1998008868-A1 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 1998-03-05 | — | — | WO | claimed |
| US-5504076-A | Cephalosporin compounds | PFIZER INC. (US) | 1996-04-02 | — | — | US | claimed |
| US-5275816-A | Cephalosporin derivatives | BEECHAM GROUP P.L.C. (GB) | 1994-01-04 | — | — | US | claimed |
| EP-0416814-A2 | Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates | BEECHAM GROUP PLC (GB) | 1991-03-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090324750-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PSEUDOLYSIMACHION LONGIFOLIUM AND THE CATALPOL DERIVATIVES ISOLATED THEREFROM HAVING ANTIINFLAMMATORY, ANTIALLERGIC AND ANTIASTHMATIC ACTIVITY | IL4, IL5, MMP13 | XDH 4207/4885LCK 908/4885KDM4E 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.